1. Pro Generika. Generika in Zahlen: Das Jahr 2017. https://www.progenerika.de/wp-content/uploads/2018/04/Generika-in-Zahlen_Das-Jahr-2017_ES.pdf. Accessed 6 Jan 2020.
2. European Medicines Agency. Committee for Medicinal Products for Human Use. Guideline on the investigation on bioequivalence EMA: CPMP/EWP/QWP/1401/98. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-investigation-bioequivalence-rev1_en.pdf. Accessed 6 Jan 2020.
3. Guideline Center for Drug Evaluation and Research, US Food and Drug Administration. Guidance for Industry: Bioavailability and Bioequivalence Studies Submitted in NDAs or INDs—General Considerations. 2019. https://www.fda.gov/media/121311/download. Accessed 6 Jan 2020.
4. Davit BM, Nwakama PE, Buehler GJ, Conner DP, Haidar SH, Patel DT, et al. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration. Ann Pharmacother. 2009;43:1583–97.
5. Finnish Medicines Agency. Generic products and generic substitution. https://www.fimea.fi/web/en/for_public/generic_products_and_generic_substitution. Accessed 6 Jan 2020.